CIBC Downgrades Cott Corp (COT) to Sector Perform
More News related to COT
- Stifel Nicolaus Downgrades Cott Corp. (COT) to Hold
- Critical Outcome Technologies Inc. Announces Board Changes
- Critical Outcome Technologies Inc. Announces Board Changes
- Oral Coti-2 Is Effective in a Second Animal Model of Human Pancreatic Cancer as a Single Agent and in Combination With Abraxane(R)
- Oral Coti-2 Is Effective in a Second Animal Model of Human Pancreatic Cancer as a Single Agent and in Combination With Abraxane(R)
More News related to Downgrades
- S&P Lowers Pinnacle Entertainment (PNK) Outlook from Stable to Negative
- Mindspeed (MSPD) Moving Lower as Brigantine Downgrades to Hold
- Davenport Downgrades Electronic Arts (ERTS) to Sell; Lowers Q4, 2010-11 Estimates
- Stifel Nicolaus Downgrades Parkway Properties (PKY) to Sell
- Craig-Hallum Downgrades Terremark (TMRK) to Accumulate
CIBC downgrades Cott Corp (NYSE: COT) from Outperform to Sector Perform. Price target increased from $7 to $9.50.
To see more analyst ratings on COT Click Here.
Cott Corporation, a non-alcoholic beverage company, engages in the production, packaging, and distribution of retailer brand and branded bottled and canned soft drinks.
Related Categories
DowngradesStocks Mentioned
+0.20Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
